Neuroprotective Activity of Ethanolic Extract of Polyherbal Formulation on Streptozotocin Induced Alzheimer’s Disease in Mice

K Sharath Kumar, Nazia Begum, Rahul M Kakalij, Dr. Vasudha Bakshi

Abstract


 

Objective: To investigate the effect of Polyherbal Formulation on cholinergic dysfunction in STZ induced Alzheimer‟s disease (AD). Methodoloy: The current study was designed to investigate the protective effect of Polyherbal Formulation (PHF) 200 and 400mg/kg for 21days. Swiss albino mice were injected with STZ (0.5mg/kg) on 14th day of pretreatment with PHF. Behavior pattern was assessed using Morris water maze, Y maze and Open field test. Biochemical estimations, namely brain Acetylcholinesterase (AchE), reduced glutathione (GSH), Catalase, Super oxide dismutase (SOD) and TBARS levels were performed. Results: The study showed that STZ significantly impaired learning and memory with a significant enhancement in brain AChE, TBARS and reduction in brain GSH, Catalase and SOD levels. Treatment of PHF significantly attenuated STZ induced behavioral and biochemical changes. The inhibitory effect of PHF on STZ induced dementia of AD type might be associated with its AchE inhibition and Free radical scavenging activity. Conclusion: The present study revealed that Polyherbal formulation significantly reduced AchE levels, oxidative stress, lipid peroxidation and cognitive impairment. The neuroprotective effect of Polyherbal Formulation might be associated with its antioxidant and anti-cholinesterase activities.


Keywords


Neuroprotective activity; Ethanolic Extract; Polyherbal Formulation; Streptozotocin; Alzheimer’s Disease;

Full Text:

PDF

References


Ahlenmeyer B, Bauerbach E, Path M, Steuber M, Heers C, Tegmeir F (2001). Retinoic acid reduces apoptosis and oxidative stress by preservation of SOD protein level. Free.Radic. Biol. Med. 30 (5):1067-1077.

Arnaiz E, Jelic V, Almkvist O, Wahlund LO, Winblad B, Valind S (2001). Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. Neuroreport. 12, 851–5.

Badruzzaman Khan, Mohd. Moshahid Khan, Andleeb Khan, Md. Ejaz Ahmed, Tauheed Ishrat, Rizwana Tabassum, Kumar Vaibhav, Ajmal Ahmad, Fakhrul Islam (2012). Naringenin ameliorates Alzheimer’s disease (AD)-type neurodegeneration with cognitive impairment (AD-TNDCI) caused by the intracerebroventricular streptozotocin in rat model. Neurochemistry International. 61:1081–1093.

Coyle JT, Donald LP, Delong MR (1983). Alzheimer's disease: d disorder of cortical cholinergic innervation. Science, 1184-1186.

Davies P, Maloney AJ (1976). Selective loss of central cholinergic neurons in Alzheimer’s disease. Lancet. 2:1403.

Davies P, Maloney AJ (1976). Selective loss of central cholinergic neurons in Alzheimer’s disease. Lancet. 2:1403.

Decker MW, Brioni JD, Bannon AW, Arnene SP (1995). Diversity of neuronal nicotinic acetylcholine receptors: lessons from behaviour and implications for CNS therapeutics. Life sci. 2:545-570.

Drachman DA, Noffsinger D, Sahakian BJ, Kurdzeil S, Fleming P (1980). Aging, memory and the cholinergic system: a study of dichotic listening. Neurobiol Aging. 1:39-43.

Dunnett SB, Wareham, AT, Torres EM (1990). Cholinergic blocked in prefrontal cortex and hippocampus disrupts short term memory in rats . Neuro Report. 1:61-64.

Ellman GL, Courtney DK, Andres V, Feathstone RM, (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 7:88–95.

Gibson GE, Peterson C, Jenden DJ (1981). Brain acetylcholine synthesis declines with senescence . Science. 213:673-676

Lannert H, Hoyer S (1998). Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav Neurosci. 112:1199–208.

Laursen SE, Belknap JK (1986). Intracerebroventricular Injections in mice. Some methodological refinements. J Pharmacol Methods. 16(4):355-7.

Levin ED, Esiner B (1994). Nicotine interactions with dopamine agonists, effects on working memory function. Drug Dev Res. 31:32-37.

Maria RR, Ivan I, Maria CBR, Jose AZ, Daniela B, Amelia TH (2005). ‘Effect of lyophilised Vaccinium berries on memory, anxiety and locomotion in adult rats’, Pharmacological Research. 52:457–462

Martinez M, Ferrandiz ML, De Juan E, Miquel J (1994). Age-related changes in glutathione and lipid peroxide content in mouse synaptic mitochondria: relationship to cytochrome c oxidase decline. Neurosci Lett. 170:121–4.

Morris RGM (1984). Developments of a water maze producer for studying spatial learning in the rats. J Neurosci Meth. 11:47–60.

Nitsch R, and Hoyer S (1991). Local action of the diabetogenic drug, streptozotocin, on glucose and energy metabolism in rat brain cortex. 128:199–202.

Olanow CW (1993). A radical hypothesis for neurodegeneration. Trends Neurosci. 16:439–44.

Parle M, Singh N (2004). Animal models for testing memory. Asia Pacific J Pharmacol. 16:101–20.

Gasbarri A (1993), Intrioni collision, IB., Pckard, MG., Pacitti, C., and Mcgaugh, JL. Interaction of cholinergic dopaminergic systems in the regulation of memory storage in aversively motivated learning tasks. Brain Res. 627:72-78.

Gibson GE, Peterson C, Jenden DJ (1981). Brain acetylcholine synthesis declines with senescence . Science. 213:673-676.

Kaur B, Singh N, Jaggi AS, (2009). Exploring mechanism of pioglitazone induced memory restorative effect in experimental dementia. Fundam Clin Pharmacol. 23:557-566.

Perry EK (1986). The cholinergic hypothesis. Br Med Bull. 42:63-69.

Perry RT, Collins JS, Wiener H, Acton R (2001). The role of TNF and its receptors in Alzheimer’s disease. Neurobiology of Aging. 22:873-883.

Pulok, K Mukherjee, Venkatesan Kumar, Mainak Mal, Peter J Houghton (2007). Acetylcholinesterase inhibitors from plants. Phytomedicine. 14, 289-300.

Raman S. Belge , Archana R. Belge (2012). Clinical Evaluation of the Efficacy of Gomutra Aasava in Shvitra Vis-A-Vis Vitiligo. Journal of Pharmacy and Biological Sciences. Page 10-13.

Reddy, D.S (1997). ‘Assessment of no tropic and amnestic activity of centrally acting agents’, Indian Journal of Pharmacology. 29:208-221.

Riekkinen M, Sirrio J, & Reikinen Jr (1993). Pharmacological consequences of nicotinergic plus sertonergic manipulations. Brain Res. 622:139-146.

Sahgal A, Keith AB (1993). Combined sertonergic cholinergic lesions do not disrupt memory in rats. Pharmacol. 45:995-1001.

Sanja Cavar, Milka Maksimovic, (2012). Antioxidant activity of essential oil and aqueous extract of Pelargonium graveolens L'Her. Food Control. 23:263-267.

Sharma B, Singh N, Singh M (2008). Modulation of celecoxib and Streptozotocin induced experimental dementia of Alzheimer’s disease type by pitavastatin and donepezil. J Psychopharmacol. 22:162-171.

Sharma M, Gupta YK (2001). Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment. Life Sci. 2001; 68:1021–1029.

Sidharth Mehan, Rimpi Arora, Vandana Sehgal, Deepak Sharma, Garuav Sharma (2011). Dementia-A Complete Literature Review on Various Mechanisms Involves in Pathogenesis and an Intracerebroventricular Streptozotocin Induced Alzheimer’s Disease. Inflammatory Diseases Immunopathology, Clinical and Pharmacological Bases. 2 (Issue3):406-421.

Strecher J, Muller WE, Hoyer S (1997). Learning abilities depend on NMDA receptor density in hippocampus in adult rats. J Neural Transm. 104:281-289.

Tanila H, Taira T, Pieppomen TP, Honkane A (1994). Effects of sex and age on brain monoamines and spatial learning in rats . Nerobiol Aging. 15:733-741.

Tourandokht Baluchnejadmojarada, Mehrdad Roghani, (2011). Chronic epigallocatechin-3-gallate ameliorates learning and memory deficits in diabetic rats via modulation of nitric oxide and oxidative stress. Behavioural Brain Research. 224:305– 310.

Quirion R, Aubert I, Robitailley, Gauthiers S, Arauju DM, Chabot JG (1990). Neurochemical deficits in pathological brain aging specificity and possible relevance for treatment strategies. Clin Neuropharmacol.13: 373-380.

Wurtman RJ (1992). Choline metabolism as a basis for the selective vulnerability of cholinergic neurones. Trends Neurosci. 15:117-122.




DOI: http://dx.doi.org/10.21477/ijapsr.v1i1.9602

Refbacks



Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Creative Commons License
International Journal of Applied Pharmaceutical Sciences and Research by Sierra Journals is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Based on a work at http://www.sierrajournals.com/direct/index.php/IJAPSR/issue/archive.